We previously cloned heparan sulfate 6-O-sulfotransferase (HS6ST) (Habuchi, H., Kobayashi, M., and Kimata, K. (1998) J. Biol. Chem. 273, 9208 -9213). In this study, we report the cloning and characterization of three mouse isoforms of HS6ST, a mouse homologue to the original human HS6ST (HS6ST-1) and two novel HS6STs (HS6ST-2 and HS6ST-3). The cDNAs have been obtained from mouse brain cDNA library by cross-hybridization with human HS6ST cDNA. The three cDNAs contained single open reading frames that predicted type II transmembrane proteins composed of 401, 506, and 470 amino acid residues, respectively. Amino acid sequence of HS6ST-1 was 51 and 57% identical to those of HS6ST-2 and HS6ST-3, respectively. HS6ST-2 and HS6ST-3 had the 50% identity. Overexpression of each isoform in COS-7 cells resulted in about 10-fold increase of HS6ST activity. The three isoforms purified with anti-FLAG antibody affinity column transferred sulfate to heparan sulfate and heparin but not to other glycosaminoglycans. Each isoform showed different specificity toward the isomeric hexuronic acid adjacent to the targeted N-sulfoglucosamine; HS6ST-1 appeared to prefer the iduronosyl N-sulfoglucosamine while HS6ST-2 had a different preference, depending upon the substrate concentrations, and HS6ST-3 acted on either substrate. Northern analysis showed that the expression of each message in various tissues was characteristic to the respective isoform. HS6ST-1 was expressed strongly in liver, and HS6ST-2 was expressed mainly in brain and spleen. In contrast, HS6ST-3 was expressed rather ubiquitously. These results suggest that the expression of these isoforms may be regulated in tissue-specific manners and that each isoform may be involved in the synthesis of heparan sulfates with tissue-specific structures and functions.
Heparan sulfate proteoglycans (HSPGs) 1 are ubiquitously present on cell surface and in extracellular matrix including basement membrane and have divergent structures and functions (1) (2) (3) . The heparan sulfate (HS) chains in HSPGs are known to interact with a variety of proteins such as heparinbinding growth factors, extracellular matrix components, protease inhibitors, protease, and lipoprotein lipase (4 -8) . These interactions are implicated not only in various dynamic cellular behaviors including cell proliferation, differentiation, adhesion, migration, and morphology during development (9 -16) , but also in various physiological phenomena such as inflammation (17) , blood coagulation (18 -20) , and tumor cell invasion and malignancy (21) (22) (23) . Moreover, the pathogens such as bacteria, parasites, and viruses are known to infect host cells through the interactions between the cell surface HS on host cell and the coat proteins or cell surface proteins of pathogens (24, 25) .
Recently, genetic screens and analyses are suggesting not only in Drosophila but also in mammals that these interactions also play pivotal roles in embryonic development. For example, the sugarless mutant (10 -12) , which is deficient in UDP-glucose dehydrogenase, and the sulfateless mutant (13) , which is deficient in heparan sulfate N-deacetylase/N-sulfotransferase, expressed the phenotype of the wingless/Wnt mutation, and the Dally mutant, which is deficient in core protein of the glypican homologue, showed the phenotype of Dpp and/or wingless mutation (14) . More recently, it has been reported that pipe mutation affected the formation of embryonic dorsal-ventral polarity and the pipe gene encodes an enzyme similar to heparan sulfate 2-O-sulfotransferase in Drosophila (15) . Also, targeted destruction of a mouse gene encoding heparan sulfate 2-Osulfotransferase (HS2ST) caused severe developmental malfunction and resulted in lethal mutation (16) . In addition, three 1 The abbreviations used are: HSPG, heparan sulfate proteoglycan; HS6ST, heparan sulfate 6-O-sulfotransferase; mHS6ST, mouse HS6ST; HS2ST, heparan sulfate 2-O-sulfotransferase; GlcNSO 3 , N-sulfoglucosamine; GlcNSO 3 (6SO 4 different genes (EXT-1, -2, and -3) were identified for hereditary multiple exostoses, characterized by multiple cartilaginous tumors, at least two of which (EXT-1 and -2) were found to encode proteins with heparan sulfate glycosyltransferase activity (26 -28) .
Not all but most of the interactions between heparan sulfate and various functional proteins occur on some regions of the heparan sulfate with highly specific sulfated monosaccharide sequences such as binding sites for antithrombin III (18, 19) , acidic fibroblast growth factor (29 -30) , basic fibroblast growth factor (31) (32) (33) (34) (35) , and hepatocyte growth factor (36, 37) . Such regional structures are also required for the activation and subsequent signaling of functional proteins such as basic fibroblast growth factor dimerization and signaling (30, 38 -41) . It is noteworthy that sulfations at various residues of the monosaccharides, especially O-sulfation, are essential to generate those specific regional structures.
The ability of cells to produce heparan sulfate with the specific sulfated monosaccharide sequences described above depends on the specific mechanisms of heparan sulfate biosynthesis (20, 42) . Several kinds of enzymes involved in the biosynthesis of heparan sulfate have been purified and cloned (20, 28, (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) . Some of them have been shown to be present as isoforms. These isoforms play important roles in generating the specific and diverse structures of heparan sulfate. Three isoforms of N-deacetylase/N-sulfotransferases are present; these isoforms are distinguished from each other with respect to the extent of N-sulfation and the expression pattern in various tissues (57) (58) (59) . Heparan sulfate glucosaminyl 3-O-sulfotransferase was also found to exist as four isoforms with different spectra of the acceptor substrate specificity (60, 61) . Although the biosynthesis of heparan sulfate proceeds as a template free mechanism, the regulated expression of these isoforms and thus attained appropriate balance of the activities of these enzymes with different substrate specificities may allow the production of heparan sulfate with the highly specific structures.
We previously purified to homogeneity heparan sulfate 6-Osulfotransferase (HS6ST) (47) and HS2ST (48) from the medium and cell layer of Chinese hamster ovary cell culture, respectively. Subsequently, we have performed the molecular cloning of HS6ST (56) and HS2ST (53) on the basis of the partial amino acid sequences of the purified enzymes. It was curious that the recombinant human HS6ST preferred as acceptor the IdoUA-GlcNSO 3 unit to the GlcUA-GlcNSO 3 unit, while the ratios of the GlcUA-GlcNSO 3 unit to the IdoUAGlcNSO 3 unit varied among heparan sulfate preparations obtained from different tissues and different developmental stages (62) (63) (64) (65) . We therefore hypothesize that an efficient sulfation of the GlcUA-GlcNSO 3 unit might be catalyzed by other HS6STs with substrate specificities different from that of human HS6ST. In this study, we report the cloning and characterization of three HS6ST isoforms with different substrate specificities. We also describe the expression patterns in various tissues of the three isoforms. (66) . Chondroitin (squid skin) was prepared as described previously (67) .
EXPERIMENTAL PROCEDURES

Materials
Screening of gt 11 Library-Approximately 2 ϫ 10 6 plaques from the mouse brain cDNA library were screened using the human HS6ST cDNA as a probe. Hybond N ϩ nylon membrane replicas of the plaques from the gt11 cDNA library were fixed by the alkali fixation method recommended by the manufacturer and prehybridized in a solution containing 37.5% (w/v) formamide, 5ϫ SSPE (sodium chloride/sodium phosphate/EDTA buffer), 5ϫ Denhardt's solution, 0.5% (w/v) SDS, and 0.05 mg/ml denatured salmon sperm DNA for 3 h at 42°C. Hybridization was carried out at 42°C in the same buffer containing 32 P-labeled probe for 16 h. Nineteen positive clones were detected by autoradiography, and the inserted cDNA was cleaved with EcoRI digestion and subcloned into pBluescript.
DNA Sequence Analysis-The subcloned cDNAs were sequenced on both strands by the dideoxy chain termination method using Taq polymerase (dye terminator cycle sequencing; Perkin-Elmer) with DNA sequencer (Applied Biosystems PRISM 310). The DNA sequences thus obtained were compiled and analyzed using GENETYX-MAX computer programs (Software Development Co., Ltd., Tokyo, Japan). The nucleotide and deduced amino acid sequences were compared with other sequences in the nucleic acid and protein data bases of GenBank TM , DDBJ, dSTS, and dbEST.
Construction of pFLAG-CMV2-mHS6ST-1, -2, and -3-For the construction of the expression vectors, pFLAG-CMV2-mHS6ST-1, -2, and -3, the polymerase chain reaction products containing the open reading frame of 1203 base pairs from positions 280 -1482 for mouse HS6ST-1 (mHS6ST-1), 1518 base pairs from positions 2-1519 for mHS6ST-2, and 1410 base pairs from positions 114 -1523 for mHS6ST-3 were ligated into the EcoRI/ClaI site, the EcoRI/ClaI sites, and the ClaI/KpnI sites of the pFLAG-CMV2 expression vector (Eastman Kodak Co.), respectively. The inserted sequences were confirmed on a single strand as described above.
Transfection of cDNAs and Transient Expression of Heparan Sulfate 6-O-Sulfotransferases in COS-7
Cells-COS-7 cells (5.5 ϫ 10 5 ) precultured for 48 h in a 60-mm culture dish were transfected with 5 g of pFLAG-CMV2-mHS6ST-1, -2, and -3, respectively, or pFLAG-CMV2 alone. The transfection was performed using lipofectamine method according to the manufacturer's recommended protocol (TransFact, Promega). After incubation in Dulbecco's modified Eagle's medium containing 10% (v/v) fetal calf serum and antibiotics for 72 h, the cell layers were washed with Dulbecco's modified Eagle's medium alone, scraped, and homogenized in 1 ml of 10 mM Tris-HCl, pH 7.2, 0.5% (w/v) Triton X-100, 0.15 M NaCl, 20% glycerol, 10 mM MgCl 2 , and 2 mM CaCl 2 . The homogenates were subjected to stirring for 1 h and then centrifuged at 10,000 ϫ g for 30 min. FLAG fusion proteins in the supernatant (cell extract) were isolated by anti-FLAG M2 (Kodak) affinity chromatography according to the method described by the manufacturer, and the activities of HS6STs in the supernatants and FLAG-bound fractions were measured as described below.
Northern Blot Analysis-Mouse multiple tissue Northern blot filters (on which 2 g of poly(A) ϩ RNAs from various adult mouse tissues were blotted) were prehybridized in ExpressHyb Hybridization Solution TM (CLONTECH) at 68°C for 30 min and then were hybridized in the same solution containing 32 P-labeled probes (1 ϫ 10 6 cpm/ml) at 68°C for 1 h. The probes used were a 1203-base fragment at positions 280 -1482 of mHS6ST-1 cDNA, a 1501-base fragment at positions 1-1501 of mHS6ST-2 cDNA, and a 1173-base fragment at positions 1-1173 of mHS6ST-3 cDNA, respectively, and mouse ␤-actin cDNA, which were labeled with [␣-32 P]dCTP by random oligonucleotide priming (Readyto-Go DNA labeling kit, Amersham Pharmacia Biotech). The membranes were washed several times with 2ϫ SSC and 0.05% SDS at room temperature and subsequently with 0.1 ϫ SSC and 0.1% SDS at 50°C two times. The membranes were exposed to x-ray film with an intensifying screen at Ϫ80°C.
Assay for Sulfotransferase Activities and Determination of K m Values for Their Acceptor and Donor
Substrates-Sulfotransferase activities were determined as described previously. Briefly, the standard reaction mixture (50 l) contained 2.5 mol of imidazole-HCl, pH 6.8, 3.75 g of protamine chloride, 25 nmol (as hexosamine) (500 M) of acceptor glycosaminoglycans, 50 pmol of [ 
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and enzyme. After incubation for 20 min at 37°C, the reaction was stopped by heating at 100°C at 1 min. Carrier chondroitin sulfate A (0.1 mol as glucuronic acid) was added to the reaction mixture, and the 35 S-labeled polysaccharides were isolated by precipitation with ethanol containing 1.3% potassium acetate and 0.5 mM EDTA, followed by gel chromatography on a Fast desalting column to remove [ 35 S]PAPS and its degradation products. The amounts of enzymes added to the reaction mixture were chosen in order to obtain the linear incorporation of [ 35 S]sulfate. We measured 35 S incorporation activities into various glycosaminoglycans by each purified recombinant enzyme under those conditions. One unit of enzyme activity was defined as the amount required to transfer 1 pmol of sulfate/min to CDSNS-heparin.
Effects of various concentrations of acceptor glycosaminoglycans or donor substrate PAPS on sulfotransferase activities were also determined under the above standard reaction conditions. The apparent K m values for acceptor or donor substrates were calculated by doublereciprocal plotting of the incorporation activities and the substrate concentrations (Lineweaver-Burk plot).
Analysis of Enzymatic Reaction Products-Analysis of the reaction products by expressed enzymes was performed by HPLC as described previously (31) with some modifications. Briefly, 35 S-labeled products were digested with a mixture of 10 milliunits of heparitinase I, 1 milliunit of heparitinase II, and 10 milliunits of heparitinase III in 40 l of 50 mM Tris-HCl, pH 7.2, 1 mM CaCl 2 , 4 g of bovine serum albumin at 37°C for 2 h. The digests were subjected to gel chromatography of Superdex 30 pg equilibrated with 0.2 M NH 4 HCO 3 . The 35 S-labeled disaccharide fractions were injected into a PAMN column together with standard unsaturated disaccharides of the kit. Fractions of 0.6 ml were collected, and their radioactivities were measured. The 35 S-labeled products were degraded with nitrous acid at pH 1.5 (68) , and then anomalous deamination products were cleaved by the additional treatment of mild acid hydrolysis (25 mM H 2 SO 4 at 80°C for 30 min) (69) . The final products were applied onto a column of Superdex 30 pg, and the disacccharides fractions were collected and analyzed by HPLC on a Partisil-10 SAX column together with unsaturated disaccharides as internal markers.
RESULTS
Cloning of Mouse Three-isoform Homologues to Human
HS6ST cDNA-A mouse brain cDNA library was screened using human HS6ST cDNA as a probe. Nineteen positive clones were obtained from 2 ϫ 10 6 plaques. Seventeen independent clones were isolated and subcloned into pBluescripts II KS. The nucleotide sequences of inserted cDNAs were classified into three groups, and their open reading frames encoded three different proteins, which we named HS6ST-1, HS6ST-2, and HS6ST-3. The amino acid sequences of HS6ST-1, HS6ST-2, and HS6ST-3 were 96, 63, and 55% identical to the sequence of human HS6ST, respectively. These data suggested that HS6ST-1 is a mouse homologue of the original human HS6ST and that HS6ST-2 and HS6ST-3 are apparently different from HS6ST-1 and may be two additional distinct forms.
Nucleotide sequence and the predicted amino acid sequence of HS6ST-1 obtained from six clones are shown in Fig. 1 . The open reading frame predicted a protein of 401 amino acid residues with two N-linked glycosylation sites. A hydropathy plot was generated from the translated sequence and showed one prominent hydrophobic segment in the amino-terminal region, 15 residues in length, that extends from amino acid residue 8 to 22 (Fig. 4A) . Besides the high identity in amino acid sequence to human HS6ST, the length of mouse HS6ST-1 (mHS6ST-1) was the same as that of human HS6ST, suggesting that HS6ST-1 is a homologue of human HS6ST.
The nucleotide sequence and the predicted amino acid sequences of HS6ST-2 obtained from two clones are shown in Fig.  2 . Although the nucleotide sequence does not contain 5Ј-upstream region of the open reading frame enough to identify the start site for translation, nucleotide residue 2 appeared to be a potential initiation site, because the hydropathy plot of the predicted protein revealed the presence of one prominent hydrophobic segment almost in the same amino-terminal region as HS6ST-1 (16 amino acid residues from positions 8 -23 as shown in Fig. 4B ). The predicted protein was composed of 506 amino acid residues with nine N-linked glycosylation sites.
The nucleotide sequence and the predicted amino acid sequence of HS6ST-3 obtained from nine clones are shown in Fig.  3 . The predicted protein was composed of 470 amino acid residues with six potential N-linked glycosylation sites and contained one hydrophobic segment in the same amino-terminal region as HS6ST-1 (15 amino acid residues from positions 8 -22 as shown in Fig. 4C) .
Comparison among the predicted amino acid sequences of HS6ST-1, HS6ST-2, and HS6ST-3 has revealed that amino acid sequence of HS6ST-1 is 51 and 57% identical to the sequences of HS6ST-2 and HS6ST-3, respectively (Fig. 5 ). HS6ST-2 showed 50% identity to HS6ST-3 (Fig. 5) . Although only a little identity was observed in both the amino-terminal and carboxyl-terminal sequences among these isoforms, amino acid sequences of the center regions were well conserved. Both putative PAPS binding sites, which were predicted from the x-ray crystallographic analyses of estrogen sulfotransferase (70) and N-sulfotransferase (71) , were all present in these center regions of the three isoforms. Taken together, it is likely that the cloned three cDNAs may encode three isoforms of mouse HS6ST.
Expression of Mouse Three-isoform cDNAs in COS-7 Cells and Determination of Heparan Sulfate 6-O-Sulfotransferase
Activity-To investigate whether the isolated cDNAs encode proteins with heparan sulfate 6-O-sulfotransferase activity, these cDNAs were inserted in a mammalian expression vector, pFLAG-CMV2, to yield pFLAG-CMV2-mHS6ST-1, pFLAG-CMV2-mHS6ST-2, and pFLAG-CMV2-mHS6ST-3, respectively, and COS-7 cells were transfected with these vectors, or with the vector alone as a control. Sulfotransferase activities in the cell extracts from these transfected cells were determined using CDSNS-heparin as a substrate. HS6ST activities in the cells transfected with pFLAG-CMV2-mHS6ST-1, pFLAG-CMV2-mHS6ST-2, and pFLAG-CMV2-mHS6ST-3 were increased about 13-, 9-, and 10-fold over the control, respectively. Interestingly, HS2ST activities were decreased, compared with the control (Table I) . It is unlikely, however, that the decrease in the cellular HS2ST activity in the transfected cells is due to altered secretion of HS2ST induced by the transfection. The HS2ST activities in the culture media of the control and the cells transfected with the expression vectors for mHS6ST-1, mHS6ST-2, and mHS6ST-3 were 0.6, 1.4, 0.9, and 1.0 pmol/ min/2.5 ϫ 10 6 cells, respectively. These values are all too low to compensate the decrease in the cellular HS2ST activity.
These observations strongly suggested that three cloned cDNAs encoded three isoforms having the HS6ST activity. We have previously observed that the purified human HS6ST and the recombinant human HS6ST were secreted from Chinese hamster ovary cells and COS-7 cells transfected with the cDNA, respectively, to the culture medium. As observed in human HS6ST, mHS6ST-1, mHS6ST-2, and mHS6ST-3 were also secreted from the COS-7 cells transfected with the respective cDNA. The activities in the culture media after 48-h cultures were found to be 62, 50, and 64% of total HS6ST activities for mHS6ST-1, mHS6ST-2, and mHS6ST-3, respectively, whereas about 90% of the total HS6ST activity of host control COS-7 cell was found in the culture medium.
Acceptor Substrate Specificity of the Purified Recombinant Heparan Sulfate 6-O-Sulfotransferases-The three isoforms were purified with anti-FLAG antibody affinity columns as described under "Experimental Procedures." The sulfotransferase activities of the three isoforms for various heparin derivatives, heparan sulfates from different sources, and other glycosaminoglycans were investigated (Table II) . The differences in the structure of the heparin derivatives and heparan
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sulfate samples were characterized by disaccharide compositional analysis (Table III) . The three isoforms were each able to transfer sulfate to CDSNS-heparain, NS-heparosan, heparin, and heparan sulfate samples from different sources but transferred little sulfate to CDSNAc-heparin. None of the isoforms showed significant activity toward chondroitin and keratan sulfate (Table II) . It is interesting to note that, when NSheparosan was used as a substrate, marked differences in the sulfotransferase activity toward NS-heparosan were observed among the three isoforms. Under the reaction conditions indicated under "Experimental Procedures," the ratio of the activity toward NS-heparosan to that toward CDSNS-heparin was 0.16, 1.85, and 0.80 for HS6ST-1, HS6ST-2, and HS6ST-3, respectively. Since NS-heparosan contained only glucuronic acid as one component of the disaccharide unit, these observations may reflect preference of each isoform between iduronic acid and glucuronic acid as hexuronic acid residues adjacent to the targeted N-sulfoglucosamine (i.e. HS6ST-1 may prefer iduronic acid, whereas HS6ST-2 may prefer glucuronic acid, and HS6ST-3 may act on either substrate). To examine this possibility, we analyzed the structures of the 35 S-labeled products formed from CDSNS-heparin or NS-heparosan after enzymatic reaction with each isoform. The 35 S-labeled products were digested with heparitinase I, II, and III, and the disaccharide fractions were then subjected to HPLC (Fig. 6, A, B, and C) . In all of the products, most of the radioactivity in the disaccharide fractions were recovered at the position of ⌬Di-(N,6)diS, and a low level of radioactivity eluted in an unknown peak between ⌬Di-6S and ⌬Di-NS. Furthermore, HPLC analysis of 35 S-labeled disaccharides formed from the 35 S-labeled CDSNS-heparin or 35 S-labeled NS-heparosan after nitrous acid degradation at pH 1.5 showed that most of the radioactivity from the 35 S-labeled CDSNS-heparin was eluted at the position of IdoUA-AMan R (6SO 4 ) (closed circles in Fig. 6, D-F) , whereas most of the radioactivity from 35 S-labeled NS-heparosan was at the position of GlcUA-AMan R (6SO 4 ) (open circles in Fig. 6, D-F) . Taken together, it is likely that mHS6ST-1 may transfer sulfate preferentially to position 6 of GlcNSO 3 residues in the IdoUA-GlcNSO 3 unit, while mHS6ST-2 may do so preferentially to position 6 of GlcNSO 3 residues in the GlcUA-GlcNSO 3 unit. The preference of mHS6ST-3 may be intermediate between those of mHS6ST-1 and mHS6ST-2.
We then asked how the specificity of each isoform that we observed could depend on the concentrations of the acceptor substrates (Fig. 7) . The activity of HS6ST-1 toward CDSNSheparin and NS-heparosan increased with the increase in their concentrations. The ratio of the activity toward NS-heparosan to that toward CDSNS-heparin was within the range of 0.12-0. 16 at all of the concentrations tested, indicating that the high preference of IdoUA-GlcNSO 3 unit to the GlcUA-GlcNSO 3 
and NS-heparosan also increased with the increase in their concentrations, and the ratio of the activity toward NS-heparosan to that toward CDSNS-heparin also stayed constant at all of the concentrations tested, although it was much larger than that of HS6ST-1 (0.70 -0.92). Apparent K m values of HS6ST-3 for CDSNS-heparin and NS-heparosan were 2 ϫ 10 Ϫ5 M for both. In contrast, although the activity of HS6ST-2 toward NS-heparosan increased with the increase in substrate concentrations, the activity of HS6ST-2 toward CDSNS-heparin showed a peak at 100 M and then decreased at the higher concentrations. It is interesting to note that such inhibitory effect of CDSNS-heparin was only observed on the activity of HS6ST-1, -2, and -3 . The predicted amino acid sequences were aligned using Genetyx computer program. The dashes indicate the skipped positions for alignment. The boxes indicate that the predicted amino acid in the alignment is identical among the three sequences. The putative PAPS binding sites that were predicted by x-ray crystallography analysis of estrogen sulfotransferase (69) are shown with a white box for 5Ј-phosphosulfate and black boxes for 3Ј-phosphate in PAPS, respectively.
HS6ST-2. Under the standard reaction conditions described under "Experimental Procedures" (500 M acceptor substrates) the activity of HS6ST-2 toward NS-heparosan happened to be 1.8 times as high as that toward CDSNS-heparin. Apparent K m of HS6ST-2 for NS-heparosan was calculated to be 2 ϫ 10
However, apparent K m for CDSNS-heparin could not be determined because the Lineweaver-Burk plot did not give a straight line. There are a few possibilities to explain how the activity of HS6ST-2 decreased with higher concentrations of CDSNS-heparin. HS6ST-2 may be inhibited by large amounts of the substrate, CDSNS-heparin (substrate inhibition). Alternatively, since CDSNS-heparin contains a minor but significant amount of 6-O-sulfated residues (see Table III ), HS6ST-2 may undergo product inhibition when the concentration increased. Since the addition of 2-O-desulfated heparin, which is structurally related to the putative reaction products formed by HS6ST-2 acting on CDSNS-heparin, to the reaction mixture hardly inhibited the activity of HS6ST-2 (data not shown), the possibility of the latter inhibition is unlikely.
It is also possible to regulate the activities of the three isoforms toward different acceptor substrates by the concentration of donor substrate, PAPS. We determined apparent K m values of HS6ST-1, HS6ST-2, and HS6ST-3 for PAPS. Under the standard assay conditions using 500 M CDSNS-heparin as acceptor substrate, the apparent K m values were 9.5 ϫ 10 Ϫ7 , 2.4 ϫ 10 Ϫ7 , and 3.7 ϫ 10 Ϫ7 M, respectively (Fig. 8) . These values were all lower than the concentration of PAPS (1 ϫ 10 Ϫ6 M) in the standard assay reaction mixture. We then examined the activities of the three isoforms toward CDSNS-heparin and NS-heparosan under the standard assay conditions except that the PAPS concentration was lowered to 1 ϫ 10 Ϫ8 M. There were no significant alterations of the relative activities of the three isoforms toward CDSNS-heparin and NS-heparosan at the lowered concentration of PAPS, compared with those obtained under the standard assay conditions (data not shown).
Northern Blot Analysis-A Northern blot of poly(A) ϩ RNA from various adult mouse tissues was hybridized with 32 Plabeled probes prepared from each HS6ST cDNA. As evident from Fig. 9 , the expression patterns of these isoforms were quite different from each other. A single transcript of mHS6ST-1 with 3.9 kilobases was expressed mainly in liver (Fig. 9A, lane 5) , while a single transcript of mHS6ST-2 with 4.6 kilobases was expressed mainly in the brain and spleen (Fig. 9B, lane 2 and 3) . In contrast to the above two, transcripts of mHS6ST-3 with multiple sizes (1.6, 2.0, 2.8, 4.0, and 6.5 kilobases) were expressed rather ubiquitously in most tissues examined, and their sizes tended to vary tissue-dependently (Fig. 9C) . These tissue-specific expression patterns of the three isoforms might reflect the production of heparan sulfates with tissue-specific structures. DISCUSSION We have for the first time cloned three isoforms of HS6ST from a mouse brain cDNA library and designated them HS6ST-1, HS6ST-2, and HS6ST-3. Judging from the high identity of HS6ST-1 in nucleotide and amino acid sequences with those of human HS6ST that we reported previously (56), we have suggested that the HS6ST-1 is a counterpart of human HS6ST. All of the expressed HS6ST-1, HS6ST-2, and HS6ST-3 catalyzed the transfer of sulfate from PAPS to position 6 of the N-sulfoglucosamine residue in heparan sulfate. These three isoforms preferred CDSNS-heparin to completely desulfated COS-7 cells COS-7 cells were transfected as described under "Experimental Procedures" with vector alone (pFLAG-CMV2) or plasmid containing the mHS6ST-1, -2, or -3, respectively. Enzyme activities of HS6ST and HS2ST in the cell extract were determined as described under "Exper- 
TABLE II Acceptor substrate specificities of the recombinant sulfotransferases purified by anti-FLAG antibody affinity column chromatography
Sulfotransferase activities were assayed using various glycosaminoglycans as acceptors. Sulfotransferase fractions were prepared form COS-7 cells transfected with pFLAG-CMV2-mHS6ST-1, pFLAG-CMV2-mHS6ST-2, and pFLAG-CMV2-mHS6ST-3, respectively, as described under "Experimental Procedures." Recombinant proteins were purified on the anti-FLAG antibody column. a The values indicate the relative rate of the incorporation into various substrates to that into CDSNS-heparin. The amount of each isoform used was designed to give the same rate of 35 S incorporation into CDSNS-heparin (0.35 pmol/min). 
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N-acetylated heparin as acceptor substrates. In addition, the heparitinase digestion of their 35 S-labeled products seldom yielded ⌬Di-6S (see Fig. 6 for the labeled products from CD-SNS-heparin; data not shown for those from completely desulfated N-acetylated heparin). Thus, none of these isoforms are likely to transfer sulfate to the N-acetylglucosamine residues. Since 6-O-sulfated N-acetylglucosamine residues are usually present in heparan sulfate preparations (Table III) , the lack of reactivity of the three isoforms with the N-acetylglucosamine residues suggests that other sulfotransferases for 6-O-sulfation of the N-acetylglucosamine residues may exist.
Each isoform exhibited quite different sulfation activity toward NS-heparosan and CDSNS-heparin. The sulfation rate of NS-heparosan relative to that of CDSNS-heparin was less than 0.2 for HS6ST-1 and nearly equal for HS6ST-3 when it was tested at various concentrations of both of the substrates. In addition, the K m value of HS6ST-1 for CDSNS-heparin was lower than that for NS-heparosan by 1 order of magnitude, while the K m values of HS6ST-3 for CDSNS-heparin and NSheparosan were of the same order of magnitude. Judging from these results, HS6ST-1 appeared to prefer the iduronosyl Nsulfoglucosamine unit, and HS6ST-3 acted almost equally on both the iduronosyl N-sulfoglucosamine unit and glucuronosyl N-sulfoglucosamine unit. In contrast, the preference of HS6ST-2 for these units appeared to vary depending on their concentrations. The activity of HS6ST-2 toward NS-heparosan increased with the increase in the concentration as observed with HS6ST-1 and HS6ST-3, while the activity toward CDSNSheparin showed a peak at 100 M and rapidly decreased with the further increase in the concentration. In consequence, under the standard assay conditions used in this study (500 M acceptor substrates) HS6ST-2 showed the higher activity toward NS-heparosan than toward CDSNS-heparin (the relative sulfation rate of NS-heparosan to that of CDSNS-heparin was 1.85). Since the actual concentration of acceptor substrate in the sulfation sites of cells expressing HS6ST-2 is hardly known, the physiological substrate specificity of HS6ST-2 is obscure. However, it is interesting to speculate that the expression of C and F) , respectively. The recombinant purified enzymes were prepared as described under "Experimental Procedures." A-C, labeled products by sulfotransferase reactions were digested with a mixture of heparitinases, and the disaccharides fractions were subjected to a PAMN column as described under "Experimental Procedures." D-F, the labeled products were subjected to nitrous acid degradation at pH 1.5. The degraded products with nitrous acid were first subjected to gel filtration, and the disaccharide fractions were then applied to Partisil-10 SAX column. The conditions of HPLC were as described under "Experimental Procedures. GlcUA C-5 epimerase that converts glucuronic acid to iduronic acid adjacent to the targeted N-sulfoglucosamine could regulate the sulfation of iduronosyl N-sulfoglucosamine unit by HS6ST-2, because the product by C-5 epimerase inhibits the sulfation of the iduronosyl N-sulfoglucosamine unit. Relating to this speculation, it has been observed that two different domains are present in heparan sulfate, the NS domain and NA/NS domains (42, 73) . The NS domain consists of contiguous iduronosyl N-sulfoglucosamine unit, while the NA/NS domain consists of alternate N-acetylated and N-sulfated disaccharides. The NA/NS domain is also rich in GlcUA-GlcNSO 3 units. From the acceptor specificities of the three isoforms discussed above, sulfation of position 6 of the N-sulfoglucosamine residues in the NS domain may be catalyzed by HS6ST-1, whereas sulfation of position 6 of the N-sulfoglucosamine residues in the NA/NS domain may be catalyzed by HS6ST-2 and HS6ST-3. Since no proteins have been found that are capable of binding to the structures containing GlcUA-GlcNSO 3 (6SO 4 ) unit, the biological function of these structures is obscure. However, it is of note that brain heparan sulfate was found to be rich in GlcUA-GlcNSO 3 (6SO 4 ) unit (74) . The abundant presence of GlcUA-GlcNSO 3 (6SO 4 ) unit in the brain heparan sulfate may be related to our finding that HS6ST-2 is mainly expressed in the brain (Fig. 8) . In contrast, liver heparan sulfate has been shown to be rich in the IdoUA(2SO 4 )-GlcNSO 3 (6SO 4 ) unit (37) . The highest expression level of HS6ST-1 in the liver may also be related to the abundant presence of the IdoUA(2SO 4 )-GlcNSO 3 (6SO 4 ) unit. These observations have led us to an interesting speculation that the GlcUA-GlcNSO 3 (6SO 4 ) unit, which could be formed by the activity of HS6ST-2, and IdoUAGlcNSO 3 (6SO 4 ), which could be formed by the activity of HS6ST-1, may serve as specific binding regions on heparan sulfate for unidentified ligand proteins with tissue-specific functions expressed in the brain and liver, respectively.
All three isoforms contained hydrophobic domains at the N-terminal regions, suggesting that these sulfotransferases are type II transmembrane proteins, as shown in other glycosaminoglycan sulfotransferases (20, 50, 51, 53, 56, 60, 75, 76) . It is thus likely that these isoforms are all localized to the Golgi membranes. It remains to be investigated whether these isoforms are situated at the same subcompartment of the Golgi apparatus or at different ones. The predicted amino acid sequences of mouse HS6ST-1, -2, and -3 showed no significant homology to those of any other glycosaminoglycan sulfotransferases cloned so far, except for sequences of the putative PAPS-binding sites that were found in estrogen sulfotransferase by x-ray crystallography (69) . The sequence for putative 5Ј-phosphosulfate binding site (KTGGTTF) and the sequence for putative 3Ј-phosphate binding site (RDPSVSRYLS) are well conserved among HS6ST-1, -2, and -3. In addition, it is interesting to note that the sequence of RDPS in the 3Ј-phosphate binding site is found only in O-sulfotransferases and not in N-sulfotransferases and might be involved in these O-sulfations. HS6ST-2 has a unique cluster composed of six Glu-Ser repeating units at the C-terminal domain. The function of this domain has not been studied, but the sequence appears to match the N-myristoylation site. HS6ST-3 has another unique hydrophilic sequence composed of 10 glutamic acid residues. This domain may endow the sulfotransferase molecule with a negatively charged hydrophilic surface, but the functional role of this domain is not evident.
To clarify the role of these isoforms in the biosynthesis of heparan sulfate, it is important to clear the regulation mechanism of these isoforms. Recently, glucosaminyl 3OST was found to be up-regulated by the administration of retinoic acid (77) . We have evidence to show that genomic genes of three isoforms of HS6ST consist of similar (although different in size) exon-intron constructions and are localized in different chromosomes. We are currently undertaking promoter analysis of these isoforms, which may reveal their different regulations 
